Scientific Publications

ML212: A small-molecule probe for investigating fluconazole resistance mechanisms in Candida albicans.

Publication TypeJournal Article
AuthorsYoungsaye, W., Hartland CL, Morgan BJ, Ting A., Nag PP, Vincent B., Mosher CA, Bittker JA, Dandapani S., Palmer M., Whitesell L., Lindquist S., Schreiber SL, and Munoz B.
AbstractThe National Institutes of Health Molecular Libraries and Probe Production Centers Network (NIH-MLPCN) screened >300,000 compounds to evaluate their ability to restore fluconazole susceptibility in resistant Candida albicans isolates. Additional counter screens were incorporated to remove substances inherently toxic to either mammalian or fungal cells. A substituted indazole possessing the desired bioactivity profile was selected for further development, and initial investigation of structure-activity relationships led to the discovery of ML212.
Year of Publication2013
JournalBeilstein journal of organic chemistry
Volume9
Pages1501-7
Date Published (YYYY/MM/DD)2013/01/01
DOI10.3762/bjoc.9.171
PubMedhttp://www.ncbi.nlm.nih.gov/pubmed/23946849?dopt=Abstract